Health Catalyst, Inc. (HCAT)
| Previous close | 6.05 |
| Open | 5.99 |
| Bid | 5.90 x 300 |
| Ask | 6.18 x 200 |
| Day's range | 5.96 - 6.02 |
| 52-week range | 5.45 - 14.37 |
| Volume | |
| Avg. volume | 578,977 |
| Market cap | 354.209M |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.84 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.54 |
ZacksDo Options Traders Know Something About Health Catalyst (HCAT) Stock We Don't?
Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately.
PR NewswireHealth Catalyst Acquires Oncology-Focused Health Technology Company Carevive
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer.
GlobeNewswireHealth Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector Insight Conference, being held in Boston, including a fireside chat on Tuesday, June 4, 2024, at
